Triovance is a late-preclinical stage biotechnology company transforming the treatment of diabetic foot disease. Its lead product, TRV-01, is a genetically engineered skin substitute, genetically modified to deliver insulin and VegF directly to the site of injury to enhance blood flow and improve cellular regeneration. Unlike traditional treatments, Triovance offers a low-cost, non-invasive, scalable solution that enables outpatient care to cure diabetic foot disease from within with minimal disruption to patients’ lives.
Company Details
- Employees
- 5
- Address
- Chronic Conditions Like Parkinson’s Disease
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- http://www.triovance.com
- Keywords
- Santiago.
Triovance Questions
Triovance's website is http://www.triovance.com
Triovance's LinkedIn profile is https://www.linkedin.com/company/triovance
Triovance has
5 employees.
View email and phone details for 5
employees at Triovance.
Triovance's industry is
Biotechnology Research
Triovance's top competitors are
Eedem Consulting And Solutions,
Rethiink It,
With Honey In The Heart,
Environ,
New Genesis,
Nasa,
Ranklos,
Biosynaptica,
Goldify International Limited,
Travere Therapeutics.
Triovance's categories are Biotechnology Research
